| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10001770 | HBV | ENSG00000156103.16 | protein_coding | MMP16 | No | No | 4325 | P51512 |
| TVIS10019474 | HBV | ENSG00000156103.16 | protein_coding | MMP16 | No | No | 4325 | P51512 |
| TVIS10023541 | HBV | ENSG00000156103.16 | protein_coding | MMP16 | No | No | 4325 | P51512 |
| TVIS10031274 | HBV | ENSG00000156103.16 | protein_coding | MMP16 | No | No | 4325 | P51512 |
| TVIS10043942 | HBV | ENSG00000156103.16 | protein_coding | MMP16 | No | No | 4325 | P51512 |
| TVIS10046418 | HBV | ENSG00000156103.16 | protein_coding | MMP16 | No | No | 4325 | P51512 |
| TVIS30078724 | HIV | ENSG00000156103.16 | protein_coding | MMP16 | No | No | 4325 | P51512 |
| TVIS30084492 | HIV | ENSG00000156103.16 | protein_coding | MMP16 | No | No | 4325 | P51512 |
| TVIS30079025 | HIV | ENSG00000156103.16 | protein_coding | MMP16 | No | No | 4325 | P51512 |
| TVIS30069238 | HIV | ENSG00000156103.16 | protein_coding | MMP16 | No | No | 4325 | P51512 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | MMP16 |
|---|---|
| DrugBank ID | DB00786 |
| Drug Name | Marimastat |
| Target ID | BE0001637 |
| UniProt ID | P51512 |
| Regulation Type | inhibitor |
| PubMed IDs | 10852638; 10669951 |
| Citations | Heath EI, Grochow LB: Clinical potential of matrix metalloprotease inhibitors in cancer therapy. Drugs. 2000 May;59(5):1043-55.@@Belotti D, Paganoni P, Giavazzi R: MMP inhibitors: experimental and clinical studies. Int J Biol Markers. 1999 Oct-Dec;14(4):232-8. |
| Groups | Investigational |
| Direct Classification | Secondary alcohols |
| SMILES | CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C |
| Pathways | |
| PharmGKB | PA164748329 |
| ChEMBL | CHEMBL279785 |
